nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0161	0.389	CbGbCtD
Crizotinib—ABCB1—Omeprazole—Barrett's esophagus	0.0158	0.382	CbGbCtD
Crizotinib—Dysaesthesia—Esomeprazole—Barrett's esophagus	0.0135	0.0384	CcSEcCtD
Crizotinib—Dysaesthesia—Omeprazole—Barrett's esophagus	0.0135	0.0384	CcSEcCtD
Crizotinib—PTK2—exocrine gland—Barrett's esophagus	0.01	0.0414	CbGeAlD
Crizotinib—Visual acuity reduced—Esomeprazole—Barrett's esophagus	0.00983	0.0279	CcSEcCtD
Crizotinib—Visual acuity reduced—Omeprazole—Barrett's esophagus	0.00983	0.0279	CcSEcCtD
Crizotinib—Generalised oedema—Esomeprazole—Barrett's esophagus	0.00983	0.0279	CcSEcCtD
Crizotinib—Generalised oedema—Omeprazole—Barrett's esophagus	0.00983	0.0279	CcSEcCtD
Crizotinib—CYP3A4—Omeprazole—Barrett's esophagus	0.00949	0.229	CbGbCtD
Crizotinib—PRKD1—smooth muscle tissue—Barrett's esophagus	0.00866	0.0358	CbGeAlD
Crizotinib—NEK9—digestive system—Barrett's esophagus	0.00751	0.031	CbGeAlD
Crizotinib—MET—epithelium—Barrett's esophagus	0.00748	0.0309	CbGeAlD
Crizotinib—PRKD1—digestive system—Barrett's esophagus	0.00684	0.0282	CbGeAlD
Crizotinib—BMPR1B—epithelium—Barrett's esophagus	0.00599	0.0247	CbGeAlD
Crizotinib—IGF1R—epithelium—Barrett's esophagus	0.00588	0.0243	CbGeAlD
Crizotinib—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	0.00585	0.0166	CcSEcCtD
Crizotinib—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.00585	0.0166	CcSEcCtD
Crizotinib—TIE1—epithelium—Barrett's esophagus	0.00572	0.0236	CbGeAlD
Crizotinib—MET—digestive system—Barrett's esophagus	0.00569	0.0235	CbGeAlD
Crizotinib—IGF1R—smooth muscle tissue—Barrett's esophagus	0.00566	0.0234	CbGeAlD
Crizotinib—Fluid retention—Esomeprazole—Barrett's esophagus	0.00555	0.0158	CcSEcCtD
Crizotinib—Fluid retention—Omeprazole—Barrett's esophagus	0.00555	0.0158	CcSEcCtD
Crizotinib—TIE1—smooth muscle tissue—Barrett's esophagus	0.00551	0.0227	CbGeAlD
Crizotinib—JAK3—digestive system—Barrett's esophagus	0.00502	0.0207	CbGeAlD
Crizotinib—DCLK1—digestive system—Barrett's esophagus	0.00498	0.0206	CbGeAlD
Crizotinib—STK4—digestive system—Barrett's esophagus	0.00492	0.0203	CbGeAlD
Crizotinib—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00488	0.0139	CcSEcCtD
Crizotinib—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00488	0.0139	CcSEcCtD
Crizotinib—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00486	0.0138	CcSEcCtD
Crizotinib—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00486	0.0138	CcSEcCtD
Crizotinib—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00472	0.0134	CcSEcCtD
Crizotinib—Hepatic failure—Omeprazole—Barrett's esophagus	0.00472	0.0134	CcSEcCtD
Crizotinib—RIPK2—epithelium—Barrett's esophagus	0.0047	0.0194	CbGeAlD
Crizotinib—ALK—digestive system—Barrett's esophagus	0.00465	0.0192	CbGeAlD
Crizotinib—EPHA5—digestive system—Barrett's esophagus	0.00465	0.0192	CbGeAlD
Crizotinib—PTK2B—smooth muscle tissue—Barrett's esophagus	0.00456	0.0188	CbGeAlD
Crizotinib—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00448	0.0127	CcSEcCtD
Crizotinib—Visual disturbance—Omeprazole—Barrett's esophagus	0.00448	0.0127	CcSEcCtD
Crizotinib—IGF1R—digestive system—Barrett's esophagus	0.00447	0.0185	CbGeAlD
Crizotinib—PTK2—epithelium—Barrett's esophagus	0.00436	0.018	CbGeAlD
Crizotinib—Diplopia—Esomeprazole—Barrett's esophagus	0.00425	0.0121	CcSEcCtD
Crizotinib—Diplopia—Omeprazole—Barrett's esophagus	0.00425	0.0121	CcSEcCtD
Crizotinib—AURKA—digestive system—Barrett's esophagus	0.00424	0.0175	CbGeAlD
Crizotinib—PTK2—smooth muscle tissue—Barrett's esophagus	0.0042	0.0173	CbGeAlD
Crizotinib—RPS6KB1—epithelium—Barrett's esophagus	0.0042	0.0173	CbGeAlD
Crizotinib—TYK2—smooth muscle tissue—Barrett's esophagus	0.00417	0.0172	CbGeAlD
Crizotinib—IRAK1—smooth muscle tissue—Barrett's esophagus	0.00412	0.017	CbGeAlD
Crizotinib—Face oedema—Esomeprazole—Barrett's esophagus	0.0041	0.0116	CcSEcCtD
Crizotinib—Face oedema—Omeprazole—Barrett's esophagus	0.0041	0.0116	CcSEcCtD
Crizotinib—RPS6KB1—smooth muscle tissue—Barrett's esophagus	0.00404	0.0167	CbGeAlD
Crizotinib—AXL—smooth muscle tissue—Barrett's esophagus	0.004	0.0165	CbGeAlD
Crizotinib—EPHB4—epithelium—Barrett's esophagus	0.00397	0.0164	CbGeAlD
Crizotinib—JAK2—epithelium—Barrett's esophagus	0.00394	0.0163	CbGeAlD
Crizotinib—EPHA2—epithelium—Barrett's esophagus	0.00389	0.0161	CbGeAlD
Crizotinib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00386	0.011	CcSEcCtD
Crizotinib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00386	0.011	CcSEcCtD
Crizotinib—EPHB4—smooth muscle tissue—Barrett's esophagus	0.00382	0.0158	CbGeAlD
Crizotinib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00382	0.0109	CcSEcCtD
Crizotinib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00382	0.0109	CcSEcCtD
Crizotinib—TEK—epithelium—Barrett's esophagus	0.0038	0.0157	CbGeAlD
Crizotinib—JAK2—smooth muscle tissue—Barrett's esophagus	0.0038	0.0157	CbGeAlD
Crizotinib—Muscular weakness—Omeprazole—Barrett's esophagus	0.00374	0.0106	CcSEcCtD
Crizotinib—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00374	0.0106	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00374	0.0106	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00374	0.0106	CcSEcCtD
Crizotinib—TEK—smooth muscle tissue—Barrett's esophagus	0.00366	0.0151	CbGeAlD
Crizotinib—MAP4K5—smooth muscle tissue—Barrett's esophagus	0.00366	0.0151	CbGeAlD
Crizotinib—PTK2B—digestive system—Barrett's esophagus	0.0036	0.0149	CbGeAlD
Crizotinib—RIPK2—digestive system—Barrett's esophagus	0.00357	0.0147	CbGeAlD
Crizotinib—Neutropenia—Omeprazole—Barrett's esophagus	0.00343	0.00974	CcSEcCtD
Crizotinib—Neutropenia—Esomeprazole—Barrett's esophagus	0.00343	0.00974	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00341	0.00968	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00341	0.00968	CcSEcCtD
Crizotinib—YES1—smooth muscle tissue—Barrett's esophagus	0.00338	0.014	CbGeAlD
Crizotinib—SRC—epithelium—Barrett's esophagus	0.00337	0.0139	CbGeAlD
Crizotinib—Weight decreased—Omeprazole—Barrett's esophagus	0.00332	0.00943	CcSEcCtD
Crizotinib—Weight decreased—Esomeprazole—Barrett's esophagus	0.00332	0.00943	CcSEcCtD
Crizotinib—TBK1—digestive system—Barrett's esophagus	0.00332	0.0137	CbGeAlD
Crizotinib—PTK2—digestive system—Barrett's esophagus	0.00332	0.0137	CbGeAlD
Crizotinib—TYK2—digestive system—Barrett's esophagus	0.0033	0.0136	CbGeAlD
Crizotinib—Infestation—Esomeprazole—Barrett's esophagus	0.00327	0.00929	CcSEcCtD
Crizotinib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00327	0.00929	CcSEcCtD
Crizotinib—Infestation NOS—Omeprazole—Barrett's esophagus	0.00327	0.00929	CcSEcCtD
Crizotinib—Infestation—Omeprazole—Barrett's esophagus	0.00327	0.00929	CcSEcCtD
Crizotinib—SRC—smooth muscle tissue—Barrett's esophagus	0.00325	0.0134	CbGeAlD
Crizotinib—RPS6KB1—digestive system—Barrett's esophagus	0.00319	0.0132	CbGeAlD
Crizotinib—FGR—digestive system—Barrett's esophagus	0.00317	0.0131	CbGeAlD
Crizotinib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00309	0.00879	CcSEcCtD
Crizotinib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00309	0.00879	CcSEcCtD
Crizotinib—EPHB4—digestive system—Barrett's esophagus	0.00302	0.0125	CbGeAlD
Crizotinib—JAK2—digestive system—Barrett's esophagus	0.003	0.0124	CbGeAlD
Crizotinib—Bradycardia—Omeprazole—Barrett's esophagus	0.00299	0.00849	CcSEcCtD
Crizotinib—Bradycardia—Esomeprazole—Barrett's esophagus	0.00299	0.00849	CcSEcCtD
Crizotinib—EPHA2—digestive system—Barrett's esophagus	0.00296	0.0122	CbGeAlD
Crizotinib—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00292	0.0083	CcSEcCtD
Crizotinib—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00292	0.0083	CcSEcCtD
Crizotinib—CSF1R—smooth muscle tissue—Barrett's esophagus	0.00292	0.012	CbGeAlD
Crizotinib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.0029	0.00824	CcSEcCtD
Crizotinib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.0029	0.00824	CcSEcCtD
Crizotinib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00289	0.00822	CcSEcCtD
Crizotinib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00289	0.00822	CcSEcCtD
Crizotinib—Urethral disorder—Omeprazole—Barrett's esophagus	0.00288	0.00818	CcSEcCtD
Crizotinib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00288	0.00818	CcSEcCtD
Crizotinib—Visual impairment—Esomeprazole—Barrett's esophagus	0.00283	0.00804	CcSEcCtD
Crizotinib—Visual impairment—Omeprazole—Barrett's esophagus	0.00283	0.00804	CcSEcCtD
Crizotinib—Eye disorder—Omeprazole—Barrett's esophagus	0.00274	0.00779	CcSEcCtD
Crizotinib—Eye disorder—Esomeprazole—Barrett's esophagus	0.00274	0.00779	CcSEcCtD
Crizotinib—YES1—digestive system—Barrett's esophagus	0.00267	0.011	CbGeAlD
Crizotinib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00265	0.00752	CcSEcCtD
Crizotinib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00265	0.00752	CcSEcCtD
Crizotinib—STK10—digestive system—Barrett's esophagus	0.00264	0.0109	CbGeAlD
Crizotinib—TAOK3—digestive system—Barrett's esophagus	0.00263	0.0109	CbGeAlD
Crizotinib—SRC—digestive system—Barrett's esophagus	0.00257	0.0106	CbGeAlD
Crizotinib—Malnutrition—Omeprazole—Barrett's esophagus	0.00256	0.00726	CcSEcCtD
Crizotinib—Malnutrition—Esomeprazole—Barrett's esophagus	0.00256	0.00726	CcSEcCtD
Crizotinib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.0025	0.00711	CcSEcCtD
Crizotinib—Dysgeusia—Omeprazole—Barrett's esophagus	0.0025	0.00711	CcSEcCtD
Crizotinib—Vision blurred—Omeprazole—Barrett's esophagus	0.00241	0.00684	CcSEcCtD
Crizotinib—Vision blurred—Esomeprazole—Barrett's esophagus	0.00241	0.00684	CcSEcCtD
Crizotinib—Anaemia—Esomeprazole—Barrett's esophagus	0.00236	0.00671	CcSEcCtD
Crizotinib—Anaemia—Omeprazole—Barrett's esophagus	0.00236	0.00671	CcSEcCtD
Crizotinib—ABL1—smooth muscle tissue—Barrett's esophagus	0.00231	0.00952	CbGeAlD
Crizotinib—CSF1R—digestive system—Barrett's esophagus	0.00231	0.00951	CbGeAlD
Crizotinib—Leukopenia—Omeprazole—Barrett's esophagus	0.00229	0.0065	CcSEcCtD
Crizotinib—Leukopenia—Esomeprazole—Barrett's esophagus	0.00229	0.0065	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00216	0.00614	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00216	0.00614	CcSEcCtD
Crizotinib—Infection—Omeprazole—Barrett's esophagus	0.00207	0.00589	CcSEcCtD
Crizotinib—Infection—Esomeprazole—Barrett's esophagus	0.00207	0.00589	CcSEcCtD
Crizotinib—Shock—Omeprazole—Barrett's esophagus	0.00205	0.00583	CcSEcCtD
Crizotinib—Shock—Esomeprazole—Barrett's esophagus	0.00205	0.00583	CcSEcCtD
Crizotinib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00205	0.00581	CcSEcCtD
Crizotinib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00205	0.00581	CcSEcCtD
Crizotinib—Skin disorder—Esomeprazole—Barrett's esophagus	0.00203	0.00576	CcSEcCtD
Crizotinib—Skin disorder—Omeprazole—Barrett's esophagus	0.00203	0.00576	CcSEcCtD
Crizotinib—Paraesthesia—Omeprazole—Barrett's esophagus	0.00187	0.00532	CcSEcCtD
Crizotinib—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00187	0.00532	CcSEcCtD
Crizotinib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00186	0.00528	CcSEcCtD
Crizotinib—Dyspnoea—Omeprazole—Barrett's esophagus	0.00186	0.00528	CcSEcCtD
Crizotinib—Dyspepsia—Omeprazole—Barrett's esophagus	0.00184	0.00522	CcSEcCtD
Crizotinib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00184	0.00522	CcSEcCtD
Crizotinib—ABL1—digestive system—Barrett's esophagus	0.00182	0.00752	CbGeAlD
Crizotinib—Decreased appetite—Omeprazole—Barrett's esophagus	0.00181	0.00515	CcSEcCtD
Crizotinib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00181	0.00515	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.0018	0.00512	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.0018	0.00512	CcSEcCtD
Crizotinib—Fatigue—Esomeprazole—Barrett's esophagus	0.0018	0.00511	CcSEcCtD
Crizotinib—Fatigue—Omeprazole—Barrett's esophagus	0.0018	0.00511	CcSEcCtD
Crizotinib—Constipation—Esomeprazole—Barrett's esophagus	0.00178	0.00507	CcSEcCtD
Crizotinib—Constipation—Omeprazole—Barrett's esophagus	0.00178	0.00507	CcSEcCtD
Crizotinib—Body temperature increased—Omeprazole—Barrett's esophagus	0.00165	0.00468	CcSEcCtD
Crizotinib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00165	0.00468	CcSEcCtD
Crizotinib—Asthenia—Esomeprazole—Barrett's esophagus	0.0015	0.00425	CcSEcCtD
Crizotinib—Asthenia—Omeprazole—Barrett's esophagus	0.0015	0.00425	CcSEcCtD
Crizotinib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00143	0.00405	CcSEcCtD
Crizotinib—Diarrhoea—Omeprazole—Barrett's esophagus	0.00143	0.00405	CcSEcCtD
Crizotinib—Dizziness—Omeprazole—Barrett's esophagus	0.00138	0.00392	CcSEcCtD
Crizotinib—Dizziness—Esomeprazole—Barrett's esophagus	0.00138	0.00392	CcSEcCtD
Crizotinib—Vomiting—Omeprazole—Barrett's esophagus	0.00133	0.00377	CcSEcCtD
Crizotinib—Vomiting—Esomeprazole—Barrett's esophagus	0.00133	0.00377	CcSEcCtD
Crizotinib—Rash—Esomeprazole—Barrett's esophagus	0.00132	0.00374	CcSEcCtD
Crizotinib—Rash—Omeprazole—Barrett's esophagus	0.00132	0.00374	CcSEcCtD
Crizotinib—Dermatitis—Omeprazole—Barrett's esophagus	0.00131	0.00373	CcSEcCtD
Crizotinib—Dermatitis—Esomeprazole—Barrett's esophagus	0.00131	0.00373	CcSEcCtD
Crizotinib—Nausea—Esomeprazole—Barrett's esophagus	0.00124	0.00352	CcSEcCtD
Crizotinib—Nausea—Omeprazole—Barrett's esophagus	0.00124	0.00352	CcSEcCtD
Crizotinib—CYP3A5—digestive system—Barrett's esophagus	0.00107	0.0044	CbGeAlD
Crizotinib—CYP3A4—digestive system—Barrett's esophagus	0.0008	0.0033	CbGeAlD
Crizotinib—ABCB1—epithelium—Barrett's esophagus	0.000745	0.00307	CbGeAlD
Crizotinib—ABCB1—digestive system—Barrett's esophagus	0.000567	0.00234	CbGeAlD
Crizotinib—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	9.71e-05	0.000267	CbGpPWpGaD
Crizotinib—CDK7—Cell Cycle—CDKN2A—Barrett's esophagus	9.68e-05	0.000266	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—CXCL8—Barrett's esophagus	9.56e-05	0.000263	CbGpPWpGaD
Crizotinib—LCK—B Cell Activation—RELA—Barrett's esophagus	9.55e-05	0.000262	CbGpPWpGaD
Crizotinib—JAK3—Immune System—HGF—Barrett's esophagus	9.55e-05	0.000262	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—HGF—Barrett's esophagus	9.36e-05	0.000257	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—HGF—Barrett's esophagus	9.32e-05	0.000256	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—SST—Barrett's esophagus	9.31e-05	0.000256	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—PPARG—Barrett's esophagus	9.3e-05	0.000255	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—APC—Barrett's esophagus	9.25e-05	0.000254	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—APC—Barrett's esophagus	9.25e-05	0.000254	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—PPARG—Barrett's esophagus	9.17e-05	0.000252	CbGpPWpGaD
Crizotinib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—Barrett's esophagus	8.95e-05	0.000246	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	8.91e-05	0.000245	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—GAST—Barrett's esophagus	8.84e-05	0.000243	CbGpPWpGaD
Crizotinib—TYK2—Disease—SLC9A1—Barrett's esophagus	8.79e-05	0.000241	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—APC—Barrett's esophagus	8.77e-05	0.000241	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—HGF—Barrett's esophagus	8.76e-05	0.000241	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	8.72e-05	0.00024	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—GAST—Barrett's esophagus	8.72e-05	0.000239	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—SST—Barrett's esophagus	8.66e-05	0.000238	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—RELA—Barrett's esophagus	8.62e-05	0.000237	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—HGF—Barrett's esophagus	8.51e-05	0.000234	CbGpPWpGaD
Crizotinib—RIPK2—Innate Immune System—RELA—Barrett's esophagus	8.48e-05	0.000233	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—PPARG—Barrett's esophagus	8.45e-05	0.000232	CbGpPWpGaD
Crizotinib—JAK2—Factors involved in megakaryocyte development and platelet production—TP53—Barrett's esophagus	8.41e-05	0.000231	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—PTGS2—Barrett's esophagus	8.4e-05	0.000231	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—HGF—Barrett's esophagus	8.39e-05	0.00023	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	8.35e-05	0.000229	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—GAST—Barrett's esophagus	8.27e-05	0.000227	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—RELA—Barrett's esophagus	8.24e-05	0.000226	CbGpPWpGaD
Crizotinib—ABL1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	8.23e-05	0.000226	CbGpPWpGaD
Crizotinib—BLK—Immune System—HGF—Barrett's esophagus	8.18e-05	0.000225	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	8.16e-05	0.000224	CbGpPWpGaD
Crizotinib—FGR—Immune System—HGF—Barrett's esophagus	8.16e-05	0.000224	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—RELA—Barrett's esophagus	8.14e-05	0.000224	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—CXCL8—Barrett's esophagus	8.13e-05	0.000223	CbGpPWpGaD
Crizotinib—FGR—Innate Immune System—RELA—Barrett's esophagus	8.13e-05	0.000223	CbGpPWpGaD
Crizotinib—TEK—Hemostasis—TP53—Barrett's esophagus	8.1e-05	0.000222	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—GAST—Barrett's esophagus	8.03e-05	0.00022	CbGpPWpGaD
Crizotinib—JAK2—Signaling by NGF—RELA—Barrett's esophagus	8.02e-05	0.00022	CbGpPWpGaD
Crizotinib—SRC—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	8.02e-05	0.00022	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—APC—Barrett's esophagus	8.02e-05	0.00022	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—RELA—Barrett's esophagus	7.83e-05	0.000215	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—SST—Barrett's esophagus	7.77e-05	0.000213	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—CXCL8—Barrett's esophagus	7.73e-05	0.000212	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—SST—Barrett's esophagus	7.72e-05	0.000212	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—HGF—Barrett's esophagus	7.67e-05	0.000211	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—SST—Barrett's esophagus	7.61e-05	0.000209	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—RELA—Barrett's esophagus	7.53e-05	0.000207	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—RELA—Barrett's esophagus	7.5e-05	0.000206	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—RELA—Barrett's esophagus	7.5e-05	0.000206	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—RELA—Barrett's esophagus	7.43e-05	0.000204	CbGpPWpGaD
Crizotinib—AURKA—Cell Cycle—TP53—Barrett's esophagus	7.29e-05	0.0002	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—SST—Barrett's esophagus	7.28e-05	0.0002	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—RELA—Barrett's esophagus	7.23e-05	0.000198	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—RELA—Barrett's esophagus	7.23e-05	0.000198	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	7.15e-05	0.000196	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—SST—Barrett's esophagus	7.06e-05	0.000194	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—SST—Barrett's esophagus	7.06e-05	0.000194	CbGpPWpGaD
Crizotinib—LCK—Signaling by NGF—RELA—Barrett's esophagus	7.03e-05	0.000193	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—APC—Barrett's esophagus	7.01e-05	0.000193	CbGpPWpGaD
Crizotinib—PLK4—Cell Cycle—TP53—Barrett's esophagus	6.99e-05	0.000192	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—RELA—Barrett's esophagus	6.85e-05	0.000188	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—PPARG—Barrett's esophagus	6.84e-05	0.000188	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—RELA—Barrett's esophagus	6.84e-05	0.000188	CbGpPWpGaD
Crizotinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	6.82e-05	0.000187	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—CXCL8—Barrett's esophagus	6.81e-05	0.000187	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—CXCL8—Barrett's esophagus	6.81e-05	0.000187	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—PPARG—Barrett's esophagus	6.81e-05	0.000187	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—HGF—Barrett's esophagus	6.79e-05	0.000187	CbGpPWpGaD
Crizotinib—SRC—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	6.68e-05	0.000183	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HGF—Barrett's esophagus	6.68e-05	0.000183	CbGpPWpGaD
Crizotinib—JAK2—Disease—SLC9A1—Barrett's esophagus	6.66e-05	0.000183	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—RELA—Barrett's esophagus	6.65e-05	0.000183	CbGpPWpGaD
Crizotinib—YES1—Immune System—HGF—Barrett's esophagus	6.58e-05	0.000181	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—RELA—Barrett's esophagus	6.56e-05	0.00018	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	6.51e-05	0.000179	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—GAST—Barrett's esophagus	6.5e-05	0.000179	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—CXCL8—Barrett's esophagus	6.46e-05	0.000177	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—PPARG—Barrett's esophagus	6.4e-05	0.000176	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—PPARG—Barrett's esophagus	6.36e-05	0.000175	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—APC—Barrett's esophagus	6.34e-05	0.000174	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—RELA—Barrett's esophagus	6.3e-05	0.000173	CbGpPWpGaD
Crizotinib—JAK3—GPCR downstream signaling—CXCL8—Barrett's esophagus	6.29e-05	0.000173	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—RELA—Barrett's esophagus	6.27e-05	0.000172	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HGF—Barrett's esophagus	6.24e-05	0.000172	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—RELA—Barrett's esophagus	6.22e-05	0.000171	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—RELA—Barrett's esophagus	6.22e-05	0.000171	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTGES—Barrett's esophagus	6.21e-05	0.00017	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—APC—Barrett's esophagus	6.2e-05	0.00017	CbGpPWpGaD
Crizotinib—TBK1—Immune System—RELA—Barrett's esophagus	6.12e-05	0.000168	CbGpPWpGaD
Crizotinib—CDK7—Disease—APC—Barrett's esophagus	6.11e-05	0.000168	CbGpPWpGaD
Crizotinib—JAK3—Hemostasis—TP53—Barrett's esophagus	6.11e-05	0.000168	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—GAST—Barrett's esophagus	6.08e-05	0.000167	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HGF—Barrett's esophagus	6.06e-05	0.000167	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—SST—Barrett's esophagus	6.06e-05	0.000166	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—RELA—Barrett's esophagus	6.04e-05	0.000166	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—SST—Barrett's esophagus	5.97e-05	0.000164	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—CXCL8—Barrett's esophagus	5.9e-05	0.000162	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—RELA—Barrett's esophagus	5.87e-05	0.000161	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—TP53—Barrett's esophagus	5.87e-05	0.000161	CbGpPWpGaD
Crizotinib—LCK—Disease—SLC9A1—Barrett's esophagus	5.83e-05	0.00016	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—CXCL8—Barrett's esophagus	5.71e-05	0.000157	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SST—Barrett's esophagus	5.67e-05	0.000156	CbGpPWpGaD
Crizotinib—JAK3—Immune System—RELA—Barrett's esophagus	5.54e-05	0.000152	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—RELA—Barrett's esophagus	5.54e-05	0.000152	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—RELA—Barrett's esophagus	5.51e-05	0.000151	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SST—Barrett's esophagus	5.5e-05	0.000151	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—RELA—Barrett's esophagus	5.48e-05	0.00015	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.46e-05	0.00015	CbGpPWpGaD
Crizotinib—CDK7—Cell Cycle—TP53—Barrett's esophagus	5.39e-05	0.000148	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—GAST—Barrett's esophagus	5.33e-05	0.000146	CbGpPWpGaD
Crizotinib—FGR—Hemostasis—TP53—Barrett's esophagus	5.22e-05	0.000143	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—RELA—Barrett's esophagus	5.18e-05	0.000142	CbGpPWpGaD
Crizotinib—SRC—Disease—SLC9A1—Barrett's esophagus	5.16e-05	0.000142	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—CXCL8—Barrett's esophagus	5.16e-05	0.000142	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—TP53—Barrett's esophagus	4.99e-05	0.000137	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.97e-05	0.000137	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—PPARG—Barrett's esophagus	4.96e-05	0.000136	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—RELA—Barrett's esophagus	4.95e-05	0.000136	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	4.94e-05	0.000136	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—RELA—Barrett's esophagus	4.94e-05	0.000136	CbGpPWpGaD
Crizotinib—LYN—Immune System—HGF—Barrett's esophagus	4.91e-05	0.000135	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—RELA—Barrett's esophagus	4.89e-05	0.000134	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HGF—Barrett's esophagus	4.89e-05	0.000134	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—RELA—Barrett's esophagus	4.87e-05	0.000134	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—RELA—Barrett's esophagus	4.87e-05	0.000134	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—RELA—Barrett's esophagus	4.85e-05	0.000133	CbGpPWpGaD
Crizotinib—BLK—Immune System—RELA—Barrett's esophagus	4.75e-05	0.00013	CbGpPWpGaD
Crizotinib—FGR—Immune System—RELA—Barrett's esophagus	4.73e-05	0.00013	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—GAST—Barrett's esophagus	4.72e-05	0.00013	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	4.7e-05	0.000129	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—RELA—Barrett's esophagus	4.7e-05	0.000129	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGES—Barrett's esophagus	4.68e-05	0.000129	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—CXCL8—Barrett's esophagus	4.67e-05	0.000128	CbGpPWpGaD
Crizotinib—CDK7—Disease—PTGS2—Barrett's esophagus	4.64e-05	0.000128	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HGF—Barrett's esophagus	4.59e-05	0.000126	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—APC—Barrett's esophagus	4.58e-05	0.000126	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—RELA—Barrett's esophagus	4.58e-05	0.000126	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—CXCL8—Barrett's esophagus	4.57e-05	0.000125	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SST—Barrett's esophagus	4.45e-05	0.000122	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—TP53—Barrett's esophagus	4.27e-05	0.000117	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—TP53—Barrett's esophagus	4.21e-05	0.000116	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—TP53—Barrett's esophagus	4.18e-05	0.000115	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—TP53—Barrett's esophagus	4.18e-05	0.000115	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SST—Barrett's esophagus	4.17e-05	0.000115	CbGpPWpGaD
Crizotinib—TYK2—Disease—APC—Barrett's esophagus	4.16e-05	0.000114	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—APC—Barrett's esophagus	4.08e-05	0.000112	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—APC—Barrett's esophagus	4.03e-05	0.000111	CbGpPWpGaD
Crizotinib—LCK—Immune System—HGF—Barrett's esophagus	4.02e-05	0.000111	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—RELA—Barrett's esophagus	4.02e-05	0.00011	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—RELA—Barrett's esophagus	4.01e-05	0.00011	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—TP53—Barrett's esophagus	3.96e-05	0.000109	CbGpPWpGaD
Crizotinib—PTK2—Immune System—RELA—Barrett's esophagus	3.87e-05	0.000106	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—APC—Barrett's esophagus	3.85e-05	0.000106	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—RELA—Barrett's esophagus	3.85e-05	0.000106	CbGpPWpGaD
Crizotinib—YES1—Immune System—RELA—Barrett's esophagus	3.82e-05	0.000105	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—APC—Barrett's esophagus	3.74e-05	0.000103	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SST—Barrett's esophagus	3.65e-05	0.0001	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—CXCL8—Barrett's esophagus	3.63e-05	9.96e-05	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—TP53—Barrett's esophagus	3.62e-05	9.95e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—RELA—Barrett's esophagus	3.62e-05	9.95e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—RELA—Barrett's esophagus	3.58e-05	9.84e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HGF—Barrett's esophagus	3.56e-05	9.78e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	3.55e-05	9.75e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—RELA—Barrett's esophagus	3.55e-05	9.75e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—RELA—Barrett's esophagus	3.52e-05	9.66e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—RELA—Barrett's esophagus	3.41e-05	9.36e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	3.39e-05	9.31e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—CXCL8—Barrett's esophagus	3.37e-05	9.27e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SST—Barrett's esophagus	3.23e-05	8.88e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—APC—Barrett's esophagus	3.21e-05	8.8e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—RELA—Barrett's esophagus	3.19e-05	8.77e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—TP53—Barrett's esophagus	3.17e-05	8.7e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—APC—Barrett's esophagus	3.16e-05	8.68e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—PTGS2—Barrett's esophagus	3.16e-05	8.67e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—APC—Barrett's esophagus	3.15e-05	8.65e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—RELA—Barrett's esophagus	3.15e-05	8.64e-05	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—TP53—Barrett's esophagus	3.14e-05	8.63e-05	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—TP53—Barrett's esophagus	3.13e-05	8.59e-05	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—CXCL8—Barrett's esophagus	3.03e-05	8.32e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—RELA—Barrett's esophagus	3.01e-05	8.27e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CXCL8—Barrett's esophagus	3.01e-05	8.26e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—APC—Barrett's esophagus	3e-05	8.23e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CXCL8—Barrett's esophagus	2.96e-05	8.14e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.94e-05	8.08e-05	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—TP53—Barrett's esophagus	2.94e-05	8.08e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—RELA—Barrett's esophagus	2.92e-05	8.02e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—APC—Barrett's esophagus	2.91e-05	7.99e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.89e-05	7.93e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TP53—Barrett's esophagus	2.86e-05	7.87e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—RELA—Barrett's esophagus	2.85e-05	7.82e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CXCL8—Barrett's esophagus	2.84e-05	7.79e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—RELA—Barrett's esophagus	2.84e-05	7.79e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TP53—Barrett's esophagus	2.8e-05	7.7e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—APC—Barrett's esophagus	2.76e-05	7.58e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CXCL8—Barrett's esophagus	2.75e-05	7.56e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CXCL8—Barrett's esophagus	2.75e-05	7.55e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—RELA—Barrett's esophagus	2.67e-05	7.32e-05	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—TP53—Barrett's esophagus	2.58e-05	7.07e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2.56e-05	7.03e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—RELA—Barrett's esophagus	2.5e-05	6.88e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—RELA—Barrett's esophagus	2.47e-05	6.78e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—APC—Barrett's esophagus	2.44e-05	6.71e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—PTGS2—Barrett's esophagus	2.39e-05	6.57e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CXCL8—Barrett's esophagus	2.36e-05	6.48e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—APC—Barrett's esophagus	2.36e-05	6.47e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—RELA—Barrett's esophagus	2.34e-05	6.43e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—RELA—Barrett's esophagus	2.33e-05	6.41e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CXCL8—Barrett's esophagus	2.33e-05	6.39e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TP53—Barrett's esophagus	2.28e-05	6.26e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—RELA—Barrett's esophagus	2.27e-05	6.25e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CXCL8—Barrett's esophagus	2.21e-05	6.06e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—APC—Barrett's esophagus	2.21e-05	6.06e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.19e-05	6.01e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CXCL8—Barrett's esophagus	2.14e-05	5.89e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—PTGS2—Barrett's esophagus	2.09e-05	5.75e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TP53—Barrett's esophagus	2.07e-05	5.69e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—RELA—Barrett's esophagus	2.07e-05	5.68e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—APC—Barrett's esophagus	1.93e-05	5.31e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—PTGS2—Barrett's esophagus	1.85e-05	5.09e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TP53—Barrett's esophagus	1.85e-05	5.07e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—RELA—Barrett's esophagus	1.84e-05	5.06e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TP53—Barrett's esophagus	1.82e-05	5e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TP53—Barrett's esophagus	1.74e-05	4.78e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CXCL8—Barrett's esophagus	1.74e-05	4.77e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—RELA—Barrett's esophagus	1.72e-05	4.73e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—APC—Barrett's esophagus	1.71e-05	4.7e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TP53—Barrett's esophagus	1.69e-05	4.64e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CXCL8—Barrett's esophagus	1.62e-05	4.46e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.58e-05	4.33e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.55e-05	4.25e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RELA—Barrett's esophagus	1.51e-05	4.15e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TP53—Barrett's esophagus	1.45e-05	3.98e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TP53—Barrett's esophagus	1.43e-05	3.92e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CXCL8—Barrett's esophagus	1.42e-05	3.91e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TP53—Barrett's esophagus	1.35e-05	3.72e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RELA—Barrett's esophagus	1.34e-05	3.67e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TP53—Barrett's esophagus	1.32e-05	3.61e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CXCL8—Barrett's esophagus	1.26e-05	3.46e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	1.22e-05	3.34e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.17e-05	3.21e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TP53—Barrett's esophagus	1.07e-05	2.93e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TP53—Barrett's esophagus	9.97e-06	2.74e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	9.19e-06	2.52e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TP53—Barrett's esophagus	8.73e-06	2.4e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TP53—Barrett's esophagus	7.73e-06	2.12e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	7.2e-06	1.98e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	5.66e-06	1.55e-05	CbGpPWpGaD
